Fear of discomfort and unnecessary treatment often deters patients from prostate cancer screening, despite the benefits of early detection. Prostate cancer can be asymptomatic, making early detection ...
The recent FDA approval of the IsoPSA blood test may represent a notable advancement in prostate cancer screening and diagnosis. Developed by Cleveland Diagnostics, the in vitro diagnostic instrument ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. For American men, prostate cancer is the most common cancer ...
KNOW. EMILY WELL, BEN JESSICA DOCTORS SAY IT WAS SYMPTOMS THAT HELPED LEAD TO THE FORMER PRESIDENT’S DIAGNOSIS. BUT THE CHIEF OF UROLOGY AT UMASS MEMORIAL MEDICAL CENTER SAYS SCREENING CAN BE ONE OF ...
A surge in the rate of incurable prostate cancer cases could be a sign to rethink Canada’s stance on screening for one of the ...
MyOme, a leading clinical whole-genome testing and polygenic risk modeling (PRS) company, today announced the launch of its Prostate Cancer Integrated Polygenic Risk Score™ (iPRS) test — a ...
A large primary care analysis shows prostate cancer screening remains underused and inequitable, with notable gaps for African American and low-income high-risk patients despite multiple risk factors.
Out of every 100 American men, about 13 will get prostate cancer during their lifetime, according to the Centers for Disease Control and Prevention. About 2 to 3 men out of 100 will die from prostate ...
It recommends that only men with a confirmed genetic risk of prostate cancer should be screened for the disease.
The Sabres and Roswell Park will hold their next free prostate cancer screening event at KeyBank Center on Tuesday, Nov. 25 ...
Chris Hoy ‘disappointed’ by prostate cancer screening decision - The six-time Olympic gold medallist expressed “sadness” at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback